LAROSA JOSEPH J
Reporting owner on Forms 3, 4 and 5, CIK 1238303.
LAROSA JOSEPH J reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-04.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| REGN · REGENERON PHARMACEUTICALS, INC.CIK 872589 | officer (EVP General Counsel and Secret) | 1 | 2026-11-04 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-02 | M exercised | +12,283 | $381.92 | 52,058 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-02 | F withheld for tax | -8,686 | $950.5 | 43,372 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-02 | S sold | -3,939 | $965.41 | 39,433 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-02 | S sold | -527 | $966.11 | 38,906 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock, holding | 5,407 | Form 4 | ||||
| REGN · REGENERON PHARMACEUTICALS, …Common Stock, holding | 413 | Form 4 | ||||
| REGN · REGENERON PHARMACEUTICALS, …Non-Qualified Stock Option (right to bu…, derivative | 2026-11-02 | M exercised | -12,283 | $0 | 0 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001238303-26-000004 | REGENERON PHARMACEUTICALS, INC. | 2026-11-04 |